Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CBMG - ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - BLDR CBMG PFNX


CBMG - ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - BLDR CBMG PFNX

NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate:

Builders FirstSource, Inc. (NASDAQ:BLDR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with BMC Stock Holdings, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC common stock. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/builders-firstsource-inc-bldr-stock-merger-bmc/.

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. Under the terms of the merger, Cellular Biomedicine stockholders (excluding certain parties) will receive $19.75 in cash for each outstanding share of common stock held immediately prior to the effective time of the merger. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/cellular-biomedicine-group-inc-cbmg-stock-merger/.

Pfenex Inc. (NYSE:PFNX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the merger agreement, Pfenex shareholders will receive $12.00 per share in cash. In addition, Ligand will pay Pfenex shareholders $2.00 per share as a Contingent Value Right in the event a predefined regulatory milestone is achieved by December 31, 2021. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/pfenex-inc/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/605843/ALERT-Halper-Sadeh-LLP-Continues-to-Investigate-the-Following-Mergers-Shareholders-are-Encouraged-to-Contact-the-Firm-BLDR-CBMG-PFNX

Stock Information

Company Name: Cellular Biomedicine Group Inc.
Stock Symbol: CBMG
Market: NASDAQ
Website: cellbiomedgroup.com

Menu

CBMG CBMG Quote CBMG Short CBMG News CBMG Articles CBMG Message Board
Get CBMG Alerts

News, Short Squeeze, Breakout and More Instantly...